Stay updated on Pembrolizumab Combo in 1L NSCLC Maintenance Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in 1L NSCLC Maintenance Clinical Trial page.

Latest updates to the Pembrolizumab Combo in 1L NSCLC Maintenance Clinical Trial page
- Check6 days agoChange DetectedA new revision entry v3.4.3 was added to the history and the v3.4.2 entry was removed.SummaryDifference0.0%

- Check13 days agoChange DetectedStudy Status updated to Completed on 2026-02-25 and Recruitment Status added on 2026-02-12. The previous status 'Active, not recruiting' was removed on 2025-10-24.SummaryDifference0.2%

- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedRevision: v3.4.2 was added and the notice about government funding lapse, as well as Revision: v3.4.1, were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check41 days agoChange DetectedAdded an operating status notice about government funding and released Revision: v3.4.1, while removing Revision: v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check48 days agoChange DetectedThe history page now includes a glossary toggle and color-coded indicators for additions (green) and deletions (red). Revision metadata updated to v3.4.0 and the No FEAR Act data label standardized.SummaryDifference0.4%

- Check62 days agoChange DetectedThe page history now shows Revision: v3.3.4, replacing the previous v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab Combo in 1L NSCLC Maintenance Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in 1L NSCLC Maintenance Clinical Trial page.